Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8VF6

Crystal structure of Serine/threonine-protein kinase 33 (STK33) Kinase Domain in complex with inhibitor CDD-2211

This is a non-PDB format compatible entry.
Summary for 8VF6
Entry DOI10.2210/pdb8vf6/pdb
DescriptorSerine/threonine-protein kinase 33, {3-[([1,1'-biphenyl]-2-yl)ethynyl]-1H-indazol-5-yl}[(3R)-3-(dimethylamino)pyrrolidin-1-yl]methanone (3 entities in total)
Functional Keywordskinase, stk33, cytosolic protein
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight65938.19
Authors
Ta, H.M.,Kim, C.,Ku, K.A.,Matzuk, M.M. (deposition date: 2023-12-21, release date: 2024-06-05)
Primary citationKu, A.F.,Sharma, K.L.,Ta, H.M.,Sutton, C.M.,Bohren, K.M.,Wang, Y.,Chamakuri, S.,Chen, R.,Hakenjos, J.M.,Jimmidi, R.,Kent, K.,Li, F.,Li, J.Y.,Ma, L.,Madasu, C.,Palaniappan, M.,Palmer, S.S.,Qin, X.,Robers, M.B.,Sankaran, B.,Tan, Z.,Vasquez, Y.M.,Wang, J.,Wilkinson, J.,Yu, Z.,Ye, Q.,Young, D.W.,Teng, M.,Kim, C.,Matzuk, M.M.
Reversible male contraception by targeted inhibition of serine/threonine kinase 33.
Science, 384:885-890, 2024
Cited by
PubMed Abstract: Men or mice with homozygous serine/threonine kinase 33 () mutations are sterile owing to defective sperm morphology and motility. To chemically evaluate STK33 for male contraception with STK33-specific inhibitors, we screened our multibillion-compound collection of DNA-encoded chemical libraries, uncovered potent STK33-specific inhibitors, determined the STK33 kinase domain structure bound with a truncated hit CDD-2211, and generated an optimized hit CDD-2807 that demonstrates nanomolar cellular potency (half-maximal inhibitory concentration = 9.2 nanomolar) and favorable metabolic stability. In mice, CDD-2807 exhibited no toxicity, efficiently crossed the blood-testis barrier, did not accumulate in brain, and induced a reversible contraceptive effect that phenocopied genetic perturbations without altering testis size. Thus, STK33 is a chemically validated, nonhormonal contraceptive target, and CDD-2807 is an effective tool compound.
PubMed: 38781365
DOI: 10.1126/science.adl2688
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.7 Å)
Structure validation

236371

PDB entries from 2025-05-21

PDB statisticsPDBj update infoContact PDBjnumon